CD274 and head and neck squamous cell carcinoma: First‐line treatment of patients with metastatic or unresectable recurrent HNSCC, in combination with platinum and fluorouracil (FU) for all patients and as a single agent for patients whose tumors express PD‐L1 (CPS ≥ 1) as determined by an FDA‐approved test [48]